Stocks Quest Diagnostics Inc

More

  • Winterizing Your Portfolio - A CNBC Special Report

    Stocks advanced Monday, rebounding off of their worst week since last March, as worries about Bernanke's confirmation subsided and investors scooped up bargains. Techs advanced ahead of earnings from Apple and Texas Instruments after the bell.

  • Winterizing Your Portfolio - A CNBC Special Report

    U.S. stock index futures pointed to a strong rebound Monday after Wall Street recorded its biggest losses since the end of October on Friday.

  • earnings_central_badge.jpg

    What follows is a roundup of corporate earnings reports for Monday, Jan.  25.

  • doctor

    It appears that Washington is about to enact sweeping legislation that will be the greatest shift in public policy in decades. Yes, we can bemoan the lack of a completely private enterprise driven system but the reality is Big Brother is here and he's not going away. Without a doubt there will be implications for investors that need to be considered; and it's not all bad news from an investment perspective.

  • MM_promo_Cramerica_Challenge_530x50.jpg

    The Lightning Round is extended in this CNBC.com exclusive feature.

  • Considering investors stepped into this market and bid shares higher even with unemployment at a 26-year high, is it safe to assume the bulls are back?

  • The Lightning Round is extended in this CNBC.com exclusive feature.

  • Pharma Stocks

    Critics have been saying for years that big pharma's been pi..., er, throwing away money on relatively unproductive research and development of new drugs. But a new study shows urine could eventually provide a new revenue stream.

  • Companies that provide laboratory services are down late in the day on talk that the the new Senate Finance Committee bill on healthcare will contain a co-pay for labs that will save some $20 billion over 10 years, which may put pressure on profits of those companies.

  • Washington has doubly blessed this motor maker, Cramer says.

  • This sector offers long-term growth, even in a slowdown. Even oil can’t promise that.

  • Plus, the Mad Money host reacts to the Justice Department's probe into telecom.

  • Wuest Diagnostics

    Talk about a silver lining! Quest Diagnostics reports that US workers are not using as much cocaine. Or meth.

  • Markets are bracing for a landslide of earnings news Tuesday and more focus on the Treasury's bank bailout plans.

  • Here is a breakdown of where the jobs are right now by sector. See what companies are hiring what types of jobs and in which states. Click through to see all major sectors.

  • Amid the gloom, Birinyi Associates' Cleve Rueckert found what he sees as a bright spot in the stock market. In a note, he says growth is the place to be, based on performance of the S&P's Pure Growth Index versus the S&P Pure Value Index. Here's his list of 15 stocks in the S&P 500 that fit three key growth criteria.

  • Cramer makes the call on viewers' favorite stocks.

  • Cramer makes the call on viewers' favorite stocks.

  • Following are the day’s biggest winners and losers. Find out why shares of Quest Diagnostics and Jeffries Group popped while Sears and National City dropped.

  • If the signs are right, the market could be slowing. In her first ever appearance on CNBC, the beverage giant chief executive explains why her stock is one of the best to own right now.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.